Special feature of mixed phosphotriester derivatives of cytarabine

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 17, 2009, Pages 6340-6347

  Gouy, Marie Hélène ^a   Jordheim, Lars P ^b   Lefebvre, Isabelle ^a   Cros, Emeline ^b   Dumontet, Charles ^b   Peyrottes, Suzanne ^a   Périgaud, Christian ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b INSERM   (France)

Author keywords

araC; Biotransformation; Cytotoxic nucleoside; Prodrug

Indexed keywords

BENZENE DERIVATIVE; CYTARABINE; CYTARABINE DERIVATIVE; ESTER DERIVATIVE; NUCLEOSIDE DERIVATIVE; NUCLEOTIDE DERIVATIVE; PHOSPHORUS DERIVATIVE; THIOL DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CHEMICAL MODIFICATION; CONCENTRATION RESPONSE; DECOMPOSITION; DRUG CYTOTOXICITY; DRUG DECOMPOSITION; DRUG METABOLISM; DRUG SCREENING; DRUG STABILITY; HUMAN; HUMAN CELL; LEUKEMIA L 1210; MOUSE; NONHUMAN; QUANTUM YIELD; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CYTARABINE; HUMANS; MICE; PRODRUGS;

MURINAE;

EID: 68649114340     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.07.038     Document Type: Article

References (30)

1. Jordheim L.P., and Dumontet C. Biochim. Biophys. Acta 1776 (2007) 138
2. Drontle D.P., and Wagner C.R. Mini-Rev. Med. Chem. 4 (2004) 409
3. McGuigan C., Hassan-Abdallah A., Srinivasan S., Wang Y., Siddiqui A., Daluge S.M., Gudmundsson K.S., Zhou H., McLean E.W., Peckham J.P., Burnette T.C., Marr H., Hazen R., Condreay L.D., Johnson L., and Balzarini J. J. Med. Chem. 49 (2006) 7215
4. Perrone P., Luoni G.M., Kelleher M.R., Daverio F., Angell A., Mulready S., Congiatu C., Rajyaguru S., Martin J.A., Levêque V., Le Pogam S., Najera I., Klumpp K., Smith D.B., and McGuigan C. J. Med. Chem. 50 (2007) 1840
5. Meier C., and Balzarini J. Antiviral Res. 71 (2006) 282
6. Jochum A., Schlienger N., Egron D., Peyrottes S., and Perigaud C. J. Organomet. Chem. 690 (2005) 2614
7. Peyrottes S., Egron D., Lefebvre I., Gosselin G., Imbach J.L., and Périgaud C. Mini-Rev. Med. Chem. 4 (2004) 395
8. Gröschel B., Cinatl J., Kotchetkov R., Köhl U., Rohrbach E., Kornhuber B., Bazzanini R., Périgaud C., Gosselin G., Imbach J.-L., Doerr H.W., and Cinatl J.J. In: Hidderman T. (Ed). Hematology and Blood Transfusion 39. Acute Leukemias VII. Experimental Approaches and Novel Therapies (1998), Springer, Berlin, Heidelberg 628
9. Jordheim L.P., Cros E., Gouy M.-H., Galmarini C.M., Peyrottes S., Mackey J., Perigaud C., and Dumontet C. Clin. Cancer Res. 10 (2004) 5614
10. Bazzanini R., Gouy M.-H., Peyrottes S., Gosselin G., and Périgaud C. Nucleosides Nucleotides Nucleic Acids 24 (2005) 1635
11. Placidi L., Faraj A., Loi A.G., Pierra C., Egron D., Cretton-Scott E., Gosselin G., Périgaud C., Martin L.T., Schinazi R.F., Imbach J.-L., El Kouni M.H., Bryant M.L., and Sommadossi J.P. Antiviral Chem. Chemother. 12 (2001) 99
12. Périgaud C., Gosselin G., Girardet J.-L., Korba B.E., and Imbach J.-L. Antiviral Res. 40 (1999) 167
13. Hantz O., Périgaud C., Borel C., Jamard C., Zoulim F., Trépo C., Imbach J.-L., and Gosselin G. Antiviral Res. 40 (1999) 179
14. Tan X., Boudinot F.D., Chu C.K., Egron D., Perigaud C., Gosselin G., and Imbach J.-L. Antiviral Chem. Chemother. 11 (2000) 203
15. Martin L.T., Cretton-Scott E., Placidi L., Faraj A., Loi A.G., Schinazi R.F., McClure H.M., Gosselin G., Imbach J.-L., and Sommadossi J.P. Nucleosides Nucleotides Nucleic Acids 19 (2000) 481
16. Shafiee M., Deferme S., Villard A.-L., Egron D., Gosselin G., Imbach J.-L., Lioux T., Pompon A., Varray S., Aubertin A.-M., Van Den Mooter G., Kinget R., Périgaud C., and Augustinjs P.J. J. Pharm. Sci. 90 (2001) 448
17. Boyer S.H., Sun Z., Jiang H., esterbook J., Gomez-Galeno J.E., Craigo W., reddy K.R., Ugarkar B.G., MacKenna D., and Erion M.D. J. Med. Chem. 49 (2006) 7711
18. Sommadossi, J. P.; Gosselin, G.; Pierra, C.; Périgaud, C.; Peyrottes, S. US Patent WO 2008/082601, 2008.
19. Peyrottes S., Coussot G., lefebvre I., Imbach J.-L., Gosselin G., Aubertin A.-M., and Périgaud C. J. Med. Chem. 46 (2003) 782
20. Egron D., Imbach J.-L., Gosselin G., Aubertin A.-M., and Périgaud C. J. Med. Chem. 46 (2003) 4564
21. Schlienger N., Peyrottes S., Kassem T., Imbach J.-L., Gosselin G., Aubertin A.-M., and Périgaud C. J. Med. Chem. 43 (2000) 4570
22. Villard A.-L., Coussot G., Lefebvre I., Augustijns P., Aubertin A.-M., Gosselin G., Peyrottes S., and Périgaud C. Bioorg. Med. Chem. 16 (2008) 7321
23. Razzell W.E., and Khorana H.G. J. Biol. Chem. 234 (1959) 2105
24. Lefebvre, I.; Beltran, T.; Peyrottes, S.; Périgaud, C. Biomed. Chromatogr. 2009, available online 2009 May 14.
25. Schlienger N., Peyrottes S., Aubertin A.-M., Gosselin G., Imbach J.-L., and Périgaud C. Nucleosides Nucleotides 18 (1999) 1025
26. Ullmann B. Adv. Exp. Med. Biol. 253B (1989) 415
27. Jordheim L.P., Galmarini C.M., and Dumontet C. Cancer Chemother. Pharmacol. 58 (2006) 547
28. Jordheim L.P., Guittet O., Lepoivre M., Galmarini C.M., and Dumontet C. Mol. Cancer Ther. 4 (2005) 1268
29. Lefebvre I., Périgaud C., Pompon A., Aubertin A.-M., Girardet J.-L., Kirn A., Gosselin G., and Imbach J.-L. J. Med. Chem. 38 (1995) 3941
30. Bates, R. G.; Paabo, M. In Handbook of Biochemistry. Physical and Chemical Data; p J227.